Heteroaromatic compounds; PROCESS FOR PREPARING COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND TREATMENT METHOD FOR ACUTE AND CHRONIC PAIN
BRPI0901758A2
use of telokinobufagin as an analgesic in the treatment of acute and chronic pain; pharmaceutical composition containing telokinobufagin and its use
WO2008031182A1
Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions
US2009311292A1
Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions
BRPI0705221A2
devices for the synthesis and pre-application incorporation of nitric oxide donors in macromolecular compositions
CA2657338A1
Anti-inflammatory and antiallergic cyclic peptides
EP2046815A1
Anti-inflammatory and antiallergic cyclic peptides
WO2008009085A1
Anti-inflammatory and antiallergic cyclic peptides
BRPI0604377A
stable ready-to-use propofol oil / water microemulsion
US2010004490A1
Process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether
BRPI0503817A
immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens
BRPI0503734A
pharmaceutical composition in ready-to-use morphine solution for injection and unit dosage form of morphine for epidural or intrathecal administration
MXPA06000803A
Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound.
BRPI0405842A
STABILIZED PHARMACEUTICAL COMPOSITION OF FLUOR-ETHER COMPOUND FOR ANESTHETIC USE. METHOD FOR STABILIZING A FLUOR-ETHER COMPOUND. USE OF STABILIZING AGENT TO PREVENT THE DEGRADATION OF COMPOSITE FLUOR Aether.
BR0303489A
Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound
BR0302523A
Stable pharmaceutical composition for administration of hiv protease inhibitors and process for obtaining concentrated pharmaceutical composition for administration of hiv protease inhibitors
BR0302424A
Pharmaceutical composition with enhanced bioavailability suitable for oral administration of retroviral protease inhibitors. process for preparing a concentrated pharmaceutical composition containing retroviral protease inhibitor
BR0301731A
Injectable and stable thiopental pharmaceutical composition; method for stabilizing aqueous thiopental solutions, and using thiopental to produce a medicament
BR0301968A
Ternary and quaternary eutectic mixtures composed of local anesthetic substances, their use in the preparation of pharmaceutical compositions and their use in anesthesia and topical analgesia
BR0202252A
Stable soluble pharmaceutical composition for administration of hiv protease inhibitors and process for obtaining concentrated pharmaceutical compositions for administration of hiv protease inhibitors
